skip to Main Content

The Coronavirus family is taxonomically subdivided as alpha-, beta-, gamma- and delta-coronavirus and known to cause diseases in human and non-human animals. Until recently the pathogenicity Coronaviruses was for the most part considered low, occasionally leading to acute upper respiratory infection in infants, young adults, the elderly and immune compromised patients. Interest in development of Coronavirus therapeutics and vaccines has risen in recent years due to the emergency of Severe Acute Respiratory Syndrome (SARS) Coronavirus (SARS-CoV) first reported in 2002,   Middle East Respiratory Syndrome (MERS) first reported in 2012 and SARS-CoV-2 the causative agent for COVID-19.

IBT Bioservices now offers peptide specific antigens and polyclonal antibodies to accelerate your research and development.

If you have any questions, please contact us.

NotesProduct NameTargetCat #SizeDatasheetPriceBuy
NewSARS-CoV2 full-length Spike ProteinCoronavirus0573-001100 ug$395.00
Back To Top
×Close search

IBT Bioservices continues to conduct critical work as an essential business under the State of Maryland’s COVID-19 response directive. We have implemented a risk management plan and are continually monitoring the situation to ensure continuation of research according to public health services recommended best-practices for keeping our employees and the community safe. 

The IBT Bioservices team will continue to deliver high quality products and services for every project. If you have any questions contact us at